业绩总结 - 2025年半年度报告合并财务报表注释曾填报错误[1] - 更正后境内营收增34,319,123.46元，增幅约20.9%[2][3] - 更正后境外营收减34,319,123.46元，减幅约39.7%[2][3] - 脊柱植入物耗材营收159,345,566.35元，成本55,959,740.72元[2][3] - 创伤植入物耗材营收8,804,534.34元，成本5,203,280.26元[2][3] - 有源设备及配套辅件营收78,704,430.22元，成本6,238,513.45元[2][3]